| Page 382 | Kisaco Research

Mariana Oncology

I found the conference to be comprehensive, delving into various facets of AI applications in drug discovery, ranging from target identification to the analysis of clinical trial data. The speakers provided valuable insights, and I gained a wealth of knowledge from their presentations. Additionally, the event afforded me the opportunity to network with experts in the field, further enhancing my understanding and connections within this dynamic industry.

Nobias Therapeutics

This was a great opportunity to connect closely with practitioners in the AI drug discovery space. The quality of presentations, speakers, and panels was high, and it's really great to hear what different groups are doing at the forefront of our industry.

Qiagen

The AIDDD Summit offered excellent insights from both pharma and commercial AI efforts that are difficult to find outside of an event like this.

Two Bear Capital

The role of Artificial Intelligence in drug discovery and development is rapidly evolving. The AIDDD Summit is a chance for participants to come up to speed across a range of areas, and interact with other stakeholders across the discipline.

Benevolent

I really enjoyed attending the Summit. It was well-organized with interesting topics, panel discussions, and great opportunities to network. I look forward to attending again!

AstraZeneca

The AIDDD Summit was a thought-provoking meeting of the minds across disciplines!

Exclusive speaker interviews
 

Goh Lanx

Senior Dir, Global Head of Privacy
Prudential

Goh Lanx

Senior Dir, Global Head of Privacy
Prudential

Goh Lanx

Senior Dir, Global Head of Privacy
Prudential